JG
CALA

Jefferies Group’s Calithera Biosciences, Inc CALA Stock Holding History

Jefferies Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,093
Closed -$68K – 3168
2019
Q3 		$68K Buy
+1,093
New +$87.5K ﹤0.01% 2554
2018
Q3 		– Sell
-1,371
Closed -$137K – 2850
2018
Q2 		$137K Buy
+1,371
New +$155K ﹤0.01% 2097

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jefferies Group's CALA Position: Q4 2019 in Review

Jefferies Group sold out of Calithera Biosciences, Inc (CALA) in Q4 2019, closing a stake of 1,093 shares — an estimated $68K sold.

Jefferies Group first reported a position in CALA in Q2 2018 and held it in 2 quarters. The position peaked at $137K in Q2 2018. 82 funds tracked by Wall St. Rank hold CALA as of Q4 2019.

  • Jefferies Group reported no remaining Calithera Biosciences, Inc position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 1,093 Calithera Biosciences, Inc shares in Q4 2019, an estimated $68K.
  • Jefferies Group first reported a position in Calithera Biosciences, Inc in Q2 2018 and held it in 2 quarters.
  • Jefferies Group's Calithera Biosciences, Inc position peaked at $137K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.